Should silicone gel be continued after six months of treatment for a scar?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: February 23, 2026View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Silicone Gel Application Beyond 6 Months for Scar Treatment

Silicone gel application should generally be discontinued after 6 months of treatment, as the majority of clinical improvement occurs within this timeframe and evidence does not support routine continuation beyond this period.

Evidence-Based Treatment Duration

The optimal treatment duration for silicone gel in scar management is well-established in the literature:

  • Clinical trials demonstrate that most therapeutic benefit occurs within the first 6 months of treatment. Studies evaluating silicone gel sheets show significant scar thickness reduction (mean 37%, range 20-54%) after 6 months of twice-daily application 1.

  • Early intervention yields the best results. Treatment should ideally begin as soon as an itchy red streak develops in a maturing wound, with improvement typically seen in 85% of cases during the treatment period 2.

  • The standard treatment protocol is 12-24 weeks. Most controlled trials use treatment durations of 8-24 weeks, with clinical and elastometric improvements documented at 4,8, and 12 weeks 3, 4.

Clinical Response Timeline

Understanding when to expect improvement helps determine if continuation is warranted:

  • Initial improvement appears within 4 weeks of consistent use (at least 12 hours daily), with further clinical improvement during weeks 4-8 of treatment 3.

  • Sustained benefit persists after discontinuation. Clinical improvement continues for at least 4 weeks after treatment is stopped, suggesting that the therapeutic effect is durable 3.

  • Six-month follow-up is recommended to monitor for any recurrence or progression, but this is for surveillance rather than continued active treatment 5.

When to Consider Extended Treatment

While 6 months is the standard endpoint, specific clinical scenarios may warrant reassessment:

  • If the scar shows continued active improvement at 6 months (ongoing reduction in thickness, redness, or symptoms), a case-by-case extension may be considered, though evidence for benefit beyond 6 months is lacking 1.

  • For keloid scars following surgical procedures, 24 weeks (6 months) of continuous treatment with sheet replacement every 4 weeks represents the established protocol, with no evidence supporting longer duration 4.

Prevention vs. Treatment Protocols

The duration differs slightly based on whether silicone gel is used prophylactically or therapeutically:

  • For prevention in high-risk patients (those with history of abnormal scarring), prophylactic use beginning 48 hours post-surgery and continuing for 6 months significantly reduces hypertrophic scar and keloid formation (39% vs 71% abnormal scar development) 5.

  • For established hypertrophic scars, the treatment period remains 6 months, even in relatively chronic cases 3.

Practical Monitoring Approach

Rather than automatically continuing beyond 6 months, implement this assessment strategy:

  • Evaluate scar characteristics at 6 months: Measure scar area, assess subjective symptoms (itching, redness, cramping), and document any progression or regression 4.

  • Discontinue if the scar is stable or improved with no active symptoms, as continued application beyond this point lacks evidence of additional benefit 1, 3.

  • Monitor for 4-6 months post-discontinuation to ensure sustained improvement and detect any recurrence requiring intervention 3, 5.

Important Caveats

  • Compliance is critical for success. The gel must be applied at least 12 hours daily (ideally continuously for sheets) to achieve the documented benefits 3, 2.

  • Silicone gel is well-tolerated with only occasional transient rashes or superficial maceration that resolve promptly when treatment is withdrawn 3.

  • No tissue penetration occurs. Histologic examination shows no evidence of silicone entering treated tissues, confirming the safety profile 3.

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.